Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine alone versus nifedipine + indomethacin for threatened preterm labor
PACTR202004681537890Phase 3Not yet recruiting
- Sponsor
- Mohammed Haider Hassan Ibrahim
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of nifedipine and indomethacin in Preterm labor (PTL) (2 arms), sponsored by Mohammed Haider Hassan Ibrahim. Primary endpoints: Primary efficacy outcome and Primary safety outcome. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
nifedipineindomethacin
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on PACTR202004681537890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202004681537890.